Related Experiment Video

Updated: Aug 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Inhibitory effects of antisense oligonucleotides on VEGF gene expression by human hepatocellular carcinoma cells]

Bang-dong Gong1, Wen Luo, Fang-teng Du

  • 1Department of Gastrointerology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang 330006, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|February 6, 2004
PubMed
Abstract

Insights

Antisense oligonucleotides targeting VEGF gene expression in human hepatoma cells showed sequence-specific inhibition. Oligonucleotides targeting the cap structure demonstrated the strongest inhibitory effect, suggesting potential for HCC gene therapy.

Area of Science:

  • Molecular Biology
  • Gene Expression Regulation
  • Cancer Research

Context:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Vascular Endothelial Growth Factor (VEGF) plays a crucial role in HCC angiogenesis and progression.
  • Targeting VEGF offers a potential therapeutic strategy for HCC.

Purpose:

  • To evaluate the efficacy of antisense oligonucleotides (ASOs) against different sequences of the VEGF gene.
  • To determine the sequence-specific inhibitory effects of ASOs on VEGF expression in human hepatoma cells (SMMC7721).
  • To identify the optimal ASO sequence for inhibiting VEGF gene expression.

Summary:

  • Human hepatoma SMMC7721 cells were exposed to hypoxic conditions, inducing VEGF mRNA upregulation.
  • Transfection with four different ASOs (A06513 to cap, A06514 to translation initiation, A06515 to Exon-3, A06516 to translation terminal) demonstrated sequence-specific inhibition of VEGF expression.
  • ASO A06513, targeting the VEGF cap structure, exhibited the most potent inhibition of VEGF mRNA levels compared to GAPDH.

Impact:

  • These findings highlight the potential of ASOs, particularly those targeting the VEGF cap structure, as a novel therapeutic approach for HCC.
  • The study provides a basis for developing targeted gene therapy strategies against VEGF in hepatocellular carcinoma.
  • Sequence-specific ASO design is crucial for effective gene silencing in cancer treatment.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...